IRS rolls out not-for-profit reporting rules
Comments
Some tax exempt organizations have been abusing their not for profit status for years.(www.wherethemoneygoes.com) No doubt, those that do will continue to find a way, because it is such a lucrative practice. Also, when you get right down to it, what does the IRS care? They don't get any money from not for profits anyway. Still, such public disclusure of information has potential to make the arrogant tax exempt hospitals (you know which ones you are) somewhat more accountable to the public they profess to serve. It's a start.
I can understand the parameters for non for profit hospitals;which is set up by internal revenue. Firstly, each proposal which is targetted to obtain grant monies must be specific to the need of the grant and to the non for profit hospital.
On the other hand, citizens have been writting proposals to councilmembers; to obtain street names, but the coucilmember is not in charge of changing street names, planning is.
Therefore, the internal revenue organization is adding specific rules, so non for profit hospitals can match the need with the grant. Secondly, medicare pays only 80% of the cost. However, the non for profit hosptial may not do the financial billng for patients. A larger organization might have a accounts payable department, acccounts receivable department and customer service. The application used may be the Eagle software. This means that the billing for patient care can be transferred about 6 times before the bill gets paid by medicare.
Hopefully, medicare and departments for patient billing will micromange the medicare accounts, so that consistent and effective billing can begin?
Post new comment
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies





